News
BOSTON--(BUSINESS WIRE)--Cerveau Technologies, Inc. today announced finalization of an exclusive license agreement with Merck ... stage investigational imaging agent (MK-6240) being evaluated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback